ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The Company has built a proprietary immunotherapy platform based on the Synthetic Long Peptide (SLP®) concept and AMPLIVANT®technology.

Biotechnology

ISA Pharmaceuticals

Gerben Moolhuizen

Marie-Andrée Yessine

Lisette Bevaart

Anna-Sophia Wiekmeijer

Leon Hooftman

Kees Melief

Willem-Jan Krebber

The Business Development and Strategy team at ISA Pharmaceuticals focuses on identifying growth opportunities, forging strategic partnerships, and enhancing the company's market position in the immunotherapy sector. They collaborate on developing and executing business strategies, managing intellectual property, and driving commercial initiatives to maximize the impact of ISA's innovative immunotherapeutics.

Business Development and Strategy

Project Management

Scientific Research Team

Business Development and Strategy

About

Team members

Other teams at ISA Pharmaceuticals

Project Management

Scientific Research Team